SCHEMBL19017151

SCHEMBL19017151

CC(C)(C)OC(=O)NC[C@H]1OB(O)c2c(OI)ccc(Br)c21

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LARS1 Q9P2J5 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5019537 0.89 LARS1 (0.61) LARS1
SCHEMBL469557 0.89 LARS1 (0.61) LARS1
SCHEMBL23939741 0.88 LARS1 (0.46) LARS1
SCHEMBL23939725 0.88 RPS6KA1 (0.37) LARS1
SCHEMBL19672999 0.81 RPS6KA1 (0.40)
SCHEMBL23939723 0.81 RPS6KA1 (0.40)
SCHEMBL23939742 0.78 LARS1 (0.47) LARS1
SCHEMBL23939724 0.78 LARS1 (0.43) LARS1
SCHEMBL469385 0.76 LARS1 (0.61) LARS1
SCHEMBL469421 0.76 LARS1 (0.45) LARS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251678-B1 BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS ANACOR PHARMACEUTICALS INC (US) 2021-10-20 EP disclosed
EP-3251678-A1 BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS Anacor Pharmaceuticals, Inc. (US) 2017-12-06 EP disclosed
EP-2613788-B1 BENZOXABOROLE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS ANACOR PHARMACEUTICALS INC (US) 2017-06-21 EP disclosed